CRONIC-PPF.at

Welcome

Description

Projects

Education

Faculty

• Bärnthaler
• Biasin
• Böhm
• Gorkiewicz
• Heinemann
• Heitzer
• Kargl
• Kneidinger
• Kovács
• Kwapiszewska
• Marsh
• Milger
• Sattler
• Singer
• Vesely

Supporting Members

Students

Publications

 

• Webmaster

The CRONIC-PPF Faculty

Valentina BIASIN
Priv.-Doz.in, MSc PhD

Testosterone as a prognostic and mechanistic driver of sex differences in progressive pulmonary fibrosis

1st Deputy Speaker, Division of Physiology and Pathophysiology
Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz
Phone: +43-316-385 72911,  e-mail

WWW: Forschungsportal Med Uni Graz
ORCID: 0000-0002-6277-1463
PubMed: PubMed (nih.gov)

• Profile     • Curriculum vitae     • Publications    
Education:
2025 Habilitation in Physiology and Pathophysiology, Medical University of Graz, Austria
2023 Open Innovation Course, Harvard Business School, USA
2010 –2014 PhD thesis at the Medical University of Graz – Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria
2008 –2010 Master Degree in Medical Biotechnology at the University of Trieste, Italy
Positions:
2025 – present 1st Deputy Speaker of Division of Physiology and Pathophysiology, Medical University of Graz, Austria
2024 – present Associate Faculty Member at the Medical University of Graz, Austria
2023 Research Unit Leader of Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria
2022 – present Head of the research unit "Metabolic and hormonal influences on the fate of mesenchymal cells in chronic lung diseases"
2022 – present Senior Scientist at the Division of Physiology and Pathophysiology, Medical University of Graz, Austria
2019 – 2021 Post-Doctoral trainee, Endocrinology and Diabetology Department, Medical University of Graz, Austria
2015 – 2018 Post-Doctoral trainee, Ludwig Boltzmann Institute for Lung Vascular Research, Medical University of Graz, Austria
Career breaks:
2018 – 2019 1st career break: maternity leave
2021 – 2022 2nd career break: maternity leave
Significant research achievements and awards (10 most important):
  • Project funding: INHalation of ALOXistatin against IPF – INALOX. ERDERA's first Joint Transnational Call (JTC 2025) (280,000 €; 2025 – 2028)
  • Project funding: European Respiratory Society Long Term Fellowship at Prof. Uroš Maver Laboratory (Institute of Biomedical Sciences, University of Maribor) – Development of an advanced in vitro lung model for pulmonary fibrosis research (2026 – 2027).
  • Project funding: The influence of adipsin in lung fibroblasts phenotype. Stadt Graz funding FIF-A 16-1130/2024-0001t-2025 (9,000 €)
  • Leader of Working Group 1 on the COST-EU Action Sex as a Biological Variable (SABV CA24168) (2025 – 2028)
  • Project funding: SCIENCE4ALL – Patient and Public Involvement and Engagement Implementation (PPIE) CALL 2020 – 2021 (60,000 €; 2021 – 2023)
  • Project funding: Hertha Firnberg Program – Austrian Science Fund (FWF) – Role of sclerostin in pulmonary hypertension (270,000 €; 2019)
  • Organization for the Study of Sex Differences (OSSD), Bergen, Norway, Best Poster Prize (PhD Student: Pamela Waked)
  • DACH Symposium Pulmonale Hypertonie, 2015: 1st Prize Best Poster
  • Michael Neumann Prize 2015, Outstanding Publication
  • American Thoracic Society Travel Grant 2013, Philadelphia, USA: ATS Conference